EX-10.58 2 d231890dex1058.htm EXCLUSIVE CLINICAL STUDY AND DATA LICENSE AGREEMENT [*CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ****,...Exclusive Clinical Study and Data License Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionTHIS EXCLUSIVE CLINICAL STUDY AND DATA LICENSE AGREEMENT (the “Agreement”) is made as of June 12, 2009 (the “Effective Date”) between VIROPHARMA INCORPORATED, a Delaware corporation (“ViroPharma”), and GENZYME CORPORATION, a Massachusetts corporation (“Genzyme”).
EXCLUSIVE CLINICAL STUDY AND DATA LICENSE AGREEMENTExclusive Clinical Study and Data License Agreement • February 28th, 2012 • Viropharma Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 28th, 2012 Company Industry JurisdictionTHIS EXCLUSIVE CLINICAL STUDY AND DATA LICENSE AGREEMENT (the “Agreement”) is made as of June 12, 2009 (the “Effective Date”) between VIROPHARMA INCORPORATED, a Delaware corporation (“ViroPharma”), and GENZYME CORPORATION, a Massachusetts corporation (“Genzyme”).